Amedeo Smart

Free Medical Literature Service

 

Amedeo

Rheumatoid Arthritis
  Free Subscription

Articles published in
Clin Rheumatol
    September 2025
  1. RODRIGUES LSS, Feyo VB, Provinciali LS, Pereira JJ, et al
    Association between tooth loss and clinical complications in rheumatoid arthritis: a pilot study.
    Clin Rheumatol. 2025 Sep 23. doi: 10.1007/s10067-025-07647.
    >> Share

  2. SALIEVA RS, Zhumabaeva S, Isakov U, Sakibaev K, et al
    The role of sequential biologic therapy in rheumatoid arthritis: a systematic review and meta-analysis of efficacy, safety, and predictive factors.
    Clin Rheumatol. 2025 Sep 11. doi: 10.1007/s10067-025-07636.
    >> Share

  3. ZHU K, Zhang X, Chen G, Zhu Y, et al
    Treatment effectiveness of hydroxychloroquine in patients with primary Sjogren's syndrome: a real-world Study.
    Clin Rheumatol. 2025;44:3591-3603.
    >> Share

  4. HUI M, Deng X, Wang J, Qian J, et al
    The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:3581-3590.
    >> Share

    August 2025
  5. PRASAD CB, Dhir V, Gupta R, Thomas KN, et al
    Split vs single-dose oral methotrexate in rheumatoid arthritis: a randomized controlled trial (SMART study).
    Clin Rheumatol. 2025 Aug 29. doi: 10.1007/s10067-025-07646.
    >> Share

  6. AL-JEDAI A, Al-Mudaiheem H, Alghanim N, Alhomood I, et al
    Transforming rheumatoid arthritis care: dynamic budget impact models with ACR to DAS28 mapping for anti-TNFs, JAK inhibitors, and interleukins.
    Clin Rheumatol. 2025 Aug 21. doi: 10.1007/s10067-025-07644.
    >> Share

  7. YIN J, Zhang M, Jia X
    Letter to the editor: clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 19. doi: 10.1007/s10067-025-07660.
    >> Share

  8. SUNNER S, Jones B, Jones CA, Al Hamarneh YN, et al
    Age-related disparities in biologic therapy initiation among rheumatoid arthritis patients: Insights from a large retrospective cohort study.
    Clin Rheumatol. 2025 Aug 12. doi: 10.1007/s10067-025-07615.
    >> Share

  9. LU YC, Chen YC
    Ultrasound of the wrist in low disease rheumatoid arthritis patients: Intercarpal joint is more sensitive than radio-carpal and distal radio-ulnar joint.
    Clin Rheumatol. 2025 Aug 6. doi: 10.1007/s10067-025-07625.
    >> Share

  10. CAI T, Tao Y, Pan Q, Yang L, et al
    Integrative GWAS and Mendelian randomization study of rheumatoid arthritis based on the 2019 UK Biobank questionnaire.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07590.
    >> Share

  11. LI S, Zhang J, Li J, Liu W, et al
    Nonlinear association between rheumatoid factor and interstitial lung disease risk in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07627.
    >> Share

  12. ZHANG Y, Liang Y, Liu M, Liu L, et al
    Identifying plasma proteins and immunocyte phenotypes as risk factors in rheumatoid arthritis: The role of EPHA3 and CD28(+) CD45RA(+) CD8(br) treg cells.
    Clin Rheumatol. 2025 Aug 2. doi: 10.1007/s10067-025-07605.
    >> Share

  13. DOZET M, Fugosic Mesic V, Laskarin AM, Drvar V, et al
    Salivary and serum biomarkers profile of patients with rheumatoid arthritis and temporomandibular disorders.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07593.
    >> Share

  14. ANYFANTI P, Antza C, Ainatzoglou A, Angeloudi E, et al
    Sodium, potassium intake and urinary sodium-to-potassium ratio in rheumatoid arthritis: association with markers of cardiovascular dysfunction and disease-related parameters.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07608.
    >> Share

  15. KOYAMA K, Ohba T, Koizumi R, Haro H, et al
    Prevalence and Predictors of Residual Symptoms in Rheumatoid Arthritis Patients in SDAI Remission: A Cross-Sectional Study Using the Illustrated Okomarigoto Sheet.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07592.
    >> Share

    July 2025
  16. RAO P, Jin S, Zhang B, Li R, et al
    Synovial infiltrating immune cell heterogeneity associated with synovitis severity and systemic disease activity in rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07565.
    >> Share

  17. KOMIYA Y, Sugihara T, Ishizaki T, Kimura N, et al
    The impact of aging and glucocorticoid use on physical function of older rheumatoid arthritis in remission: analysis of a National Database of Rheumatic Disease in Japan.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07599.
    >> Share

  18. ZHA X, Liu M, Ruan S, Jiang Y, et al
    Relationship between serum vitamin D levels and pro-inflammatory cytokines in patients with rheumatoid arthritis combined with cardiovascular disease.
    Clin Rheumatol. 2025 Jul 26. doi: 10.1007/s10067-025-07587.
    >> Share

  19. MAS MARIN J, Molina-Olano M, Sola NR, Miserachs-Aranda N, et al
    Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07568.
    >> Share

  20. TUZUN Z, Aydin K, Turk I, Varkal G, et al
    Evaluation of the coalescent lung ultrasound score in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07589.
    >> Share

  21. LI Z, Liu Y, Zhang Y, Zhang Z, et al
    NETs promote fibroblast-like synoviocytes producing IL-6 to enhance T follicular helper cell response in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07543.
    >> Share

  22. HUANG J, Wang L, Hu X, Wang T, et al
    Genetic and molecular underpinnings of the link between rheumatoid arthritis and myasthenia gravis: Insights from GWAS and transcriptomic analyses.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07582.
    >> Share

  23. OZ B, Dogan Y, Karatas A, Koca SS, et al
    Radiological and serological predictors of cavitary transformation in rheumatoid arthritis-associated pulmonary nodules: a retrospective cohort study.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07579.
    >> Share

  24. ZOU L, Fan Q, Liu Y, He H, et al
    Leucine-rich alpha-2-glycoprotein 1 (LRG1) decrement during biologics therapy and its correlation with disease features and treatment outcomes in rheumatoid arthritis patients.
    Clin Rheumatol. 2025 Jul 15. doi: 10.1007/s10067-025-07545.
    >> Share

  25. REN Y, Xia W, Wu J, Yang Z, et al
    Artificial intelligence-based prediction of organ involvement in Sjogren's syndrome using labial gland biopsy whole-slide images.
    Clin Rheumatol. 2025;44:2919-2927.
    >> Share

  26. CHENG F, Wang YL, Ai XY, Liu Y, et al
    Clinical features of anti-RNP-positive primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2911-2917.
    >> Share

  27. TURKMEN S, Coskuner T, Sozeri B
    Multidimensional assessment of Juvenile Sjogren disease.
    Clin Rheumatol. 2025;44:2897-2909.
    >> Share

  28. GU X, Chen Y, Xuan J, Shi Y, et al
    Positive thyroid autoantibodies in primary Sjogren syndrome define a subset of patients with milder disease.
    Clin Rheumatol. 2025;44:2889-2895.
    >> Share

  29. JONUSIENE G, Kaceniene A, Gedvilaite V, Dadoniene J, et al
    Cancer risk in patients with Sjogren's syndrome in Lithuanian cohort study.
    Clin Rheumatol. 2025;44:2883-2887.
    >> Share

    June 2025
  30. EDITH SE, Miguel P, Gabriel RM, Maria O, et al
    Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 24. doi: 10.1007/s10067-025-07510.
    >> Share

  31. AKBARI AR, Alam B
    Medication effects on uric acid levels in rheumatoid arthritis studies.
    Clin Rheumatol. 2025 Jun 20. doi: 10.1007/s10067-025-07538.
    >> Share

  32. JIN J, Xiang X, Cai X, Hou Y, et al
    Machine learning and bioinformatics analysis to identify and validate diagnostic model associated with immune infiltration in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 11. doi: 10.1007/s10067-025-07514.
    >> Share

  33. KARACAOGLU MC, Kizildag B, Okyar B, Yildirim Cetin G, et al
    Computed tomography-based quantitative scoring system for rheumatoid arthritis-associated interstitial lung disease: a retrospective diagnostic accuracy study for progressive fibrosis detection.
    Clin Rheumatol. 2025 Jun 9. doi: 10.1007/s10067-025-07511.
    >> Share

  34. OSKEN S, Osken A, Polat F, Sahin D, et al
    A retrospective study of electrocardiographic alterations in primary Sjogren's syndrome: role of anti-SSA positivity and disease duration.
    Clin Rheumatol. 2025;44:2377-2386.
    >> Share

  35. SU R, Wang H, Li B, Wu R, et al
    Low-dose IL-2 restores Tfh/Tfr imbalance and modulates B cell subset distribution in the pre-arthritis phase of the collagen-induced arthritis model.
    Clin Rheumatol. 2025;44:2487-2500.
    >> Share

  36. QI X, Zhao D, Wang N, Han Y, et al
    B lymphocyte subset-based stratification in primary Sjogren's syndrome: implications for lymphoma risk and personalized treatment.
    Clin Rheumatol. 2025;44:2403-2412.
    >> Share

  37. DOU H, Wu R, Wang H, Wang X, et al
    CCR5 + T cells as a potential biomarker for primary Sjogren's disease based on bioinformatics analysis.
    Clin Rheumatol. 2025;44:2387-2401.
    >> Share

  38. LUO Y, Mo Y, Li S, Yao J, et al
    Value of combined application of the OMERACT scoring system and shear wave elastography for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2367-2375.
    >> Share

  39. FAN R, Zhang Z, Huang Q, Liu L, et al
    Association of regional adiposity distribution with risk of autoimmune diseases.
    Clin Rheumatol. 2025;44:2541-2552.
    >> Share

  40. WANG C, Hu H, Xu Y, Wang S, et al
    Transcriptomic sequencing of multiple salivary glands combined with bioinformatics analysis reveals key genes in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2355-2365.
    >> Share

  41. WANG Z, Chen X, Zhang QB, Wang H, et al
    Exploring the genetic components and multi-omics sources of inflammatory bowel disease from the perspective of autoimmune disorders.
    Clin Rheumatol. 2025;44:2527-2539.
    >> Share

  42. DUO R, Wang Y, Ma Q, Wang X, et al
    MTX-induced gastrointestinal reactions in RA: Prevotella enrichment, gut dysbiosis, and PI3K/Akt/Ras/AMPK pathways.
    Clin Rheumatol. 2025;44:2163-2177.
    >> Share

    May 2025
  43. MUSTONEN AM, Savinainen J, Lehtonen M, Lehenkari P, et al
    Synovial fluid o-tyrosine is a potential biomarker for autoimmune-driven rheumatoid arthritis.
    Clin Rheumatol. 2025 May 31. doi: 10.1007/s10067-025-07491.
    >> Share

  44. RAO P, Jin S, Qi Y, Liu X, et al
    Clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 May 22. doi: 10.1007/s10067-025-07493.
    >> Share

  45. YAN L, Xu J, Ye X, Lin M, et al
    Development and validation of ultrasound-based radiomics deep learning model to identify bone erosion in rheumatoid arthritis.
    Clin Rheumatol. 2025 May 19. doi: 10.1007/s10067-025-07481.
    >> Share

  46. ZHENG X, Ke X, Gao J, Zheng Z, et al
    The molecular basis of all-trans retinoic acid binding to the target genes involved in rheumatoid arthritis through network pharmacology and molecular docking.
    Clin Rheumatol. 2025 May 17. doi: 10.1007/s10067-025-07482.
    >> Share

  47. WU T, Wang Y, Xia Y, Ji J, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of infectious diseases.
    Clin Rheumatol. 2025 May 16. doi: 10.1007/s10067-025-07485.
    >> Share

  48. PHAM TH, Do TTH, Nguyen TN, Luu LC, et al
    Characteristics of sarcopenia in patients with rheumatoid arthritis at a central university hospital in Hanoi, Vietnam: a cross-sectional study.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07469.
    >> Share

  49. TEMIZ KARADAG D, Dogan S, Cakir O, Altintas Y, et al
    The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07443.
    >> Share

  50. GOMES-SILVA JM, Torres CP, Teixeira LR, Saraiva MDCP, et al
    Prospective Sham-Controlled trial: acupuncture for symptom-relieving in patients with Sjogren's disease.
    Clin Rheumatol. 2025;44:1971-1982.
    >> Share

  51. LI X, Li Y, Luo Q, Yang W, et al
    Direct immunofluorescence of labial gland in diagnosis of Sjogren's disease.
    Clin Rheumatol. 2025;44:1961-1969.
    >> Share

  52. YANG Y, Zhang Y, Liu K, Liu M, et al
    IFI27, a potential candidate molecular marker for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1949-1960.
    >> Share

    April 2025
  53. XU QY, Liu YQ, Tong WQ, Yin-Ruo YR, et al
    Comparison of the clinical efficacy and pharmacoeconomics of tofacitinib and adalimumab in Chinese patients with rheumatoid arthritis: An analysis based on propensity score matching.
    Clin Rheumatol. 2025 Apr 29. doi: 10.1007/s10067-025-07431.
    >> Share

  54. MA Z, Wu S, Xiong LE, Zhong J, et al
    Interaction of nutritional and inflammatory levels on all-cause mortality among individuals with rheumatoid arthritis: a prospective cohort study.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07458.
    >> Share

  55. YANG D, Chen J, He G, Zhou Z, et al
    Comparisons of [(68) Ga]Ga-FAPI-04 PET/CT with X-ray imaging in the assessment of patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07414.
    >> Share

  56. ZHAO P, Yuan K, Tang Z, Li Y, et al
    Investigation of hub-shared genes and regulatory mechanisms of rheumatoid arthritis and atherosclerosis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07423.
    >> Share

  57. MALEKAN M, Dozandeh-Jouybari A, Sadeghian N, Soltanshahi M, et al
    SLAM receptors regulate immune checkpoints via SAP and EAT- 2 in rheumatoid arthritis: association with disease activity.
    Clin Rheumatol. 2025 Apr 26. doi: 10.1007/s10067-025-07461.
    >> Share

  58. WU Q, Zhang X, Qin M, Shi D, et al
    Dual roles of LncRNA RNA143598: a biomarker for rheumatoid arthritis and its implications in cancer.
    Clin Rheumatol. 2025 Apr 25. doi: 10.1007/s10067-025-07448.
    >> Share

  59. CELIK NC, Kilinc EA
    Assessment of ChatGPT's adherence to EULAR diagnostic criteria and therapeutic protocols for rheumatoid arthritis at two distinct time points, 14 days apart, utilizing binary and multiple-choice inquiries.
    Clin Rheumatol. 2025 Apr 22. doi: 10.1007/s10067-025-07417.
    >> Share

  60. THYBERG I, Husberg M, Kastbom A
    Physical and mental disability is evident 8 years after diagnosis in early rheumatoid arthritis despite contemporary medication and non-pharmacological interventions.
    Clin Rheumatol. 2025 Apr 9. doi: 10.1007/s10067-025-07399.
    >> Share

  61. LEBOUILLE-VELDMAN AB, Huizinga TWJ, Mekary RA, Vleggeert-Lankamp CLA, et al
    Prolonged glucocorticoid use and rheumatoid arthritis-associated cervical spine deformity.
    Clin Rheumatol. 2025 Apr 4. doi: 10.1007/s10067-025-07408.
    >> Share

  62. YANG J, Park Y, Lee JJ, Kim WU, et al
    Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity, and lymphoma risk factors in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1643-1652.
    >> Share

  63. HAKBILEN S, Tezcan D, Onmaz DE, Yilmaz S, et al
    The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1635-1642.
    >> Share

  64. HAN Y, Wang R, Sun F, Feng R, et al
    Anti-SSA/SSB antibody double-negative Sjogren's disease patients: a comprehensive clinical study and immune profile.
    Clin Rheumatol. 2025;44:1625-1633.
    >> Share

  65. XU Y, Yin Y, Li W, Zhou J, et al
    Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy.
    Clin Rheumatol. 2025;44:1705-1712.
    >> Share

    March 2025
  66. GENG L, Li T, Liu Y, Liu X, et al
    Lycium barbarum polysaccharide corrects CCR9(+) Th17/ Treg imbalance in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 27. doi: 10.1007/s10067-025-07415.
    >> Share

  67. LI F, Xian D, Yang K
    Mendelian randomization and mediation analysis reveal the role of immune cell subsets in the causal pathways between blood cell perturbation responses and rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 12. doi: 10.1007/s10067-025-07387.
    >> Share

  68. ANGELOZZI L, Gillibert A, Brevet P, Grosjean J, et al
    Comparative analysis of clinical profile, therapeutic management, and clinical prognosis of patients with seropositive or seronegative rheumatoid arthritis following the introduction of a first targeted therapy in a real-life setting.
    Clin Rheumatol. 2025 Mar 10. doi: 10.1007/s10067-025-07390.
    >> Share

  69. ZHAO C, Xiao Q, Huang W, Chen Y, et al
    Association between rheumatoid arthritis and hyperuricemia among adults: a cross-sectional study based on NHANES data.
    Clin Rheumatol. 2025 Mar 6. doi: 10.1007/s10067-025-07386.
    >> Share

  70. YU X, Xi J, Wu J, Song R, et al
    Correlation between myocardial work and disease activity in rheumatoid arthritis patients with preserved left ventricular ejection fraction: a retrospective study based on non-invasive pressure-strain loop?.
    Clin Rheumatol. 2025 Mar 5. doi: 10.1007/s10067-025-07380.
    >> Share

  71. SONG S, Yang Y, Ren T, Shen Y, et al
    Enhanced co-expression of TIGIT and PD-1 on gammadelta T cells correlates with clinical features and laboratory parameters in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1245-1257.
    >> Share

  72. PEI W, Xu L, Zhong H, Wang Z, et al
    Clinical features of inflammatory arthritis in daily practice-China's perspective.
    Clin Rheumatol. 2025;44:969-978.
    >> Share

  73. LIANG Y, Zhang Z, Li J, Yang Z, et al
    Association of increased serum I-309 with phenotypes, disease activity, and cytokine pattern in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1237-1243.
    >> Share

  74. HUGHES DM, Yiu ZZN, Zhao SS
    External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank study.
    Clin Rheumatol. 2025;44:1151-1161.
    >> Share

  75. PANG F, Jiang Q, Tang X, Li K, et al
    Fecal metabolomic analysis of the role of gut microbiota and short-chain fatty acids in the therapeutic mechanism of Timosaponin AIII in Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1209-1223.
    >> Share

  76. LIANG P, Huang Y, Hu Z, Zhou L, et al
    Clinical and laboratory characteristics of Sjogren's syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study.
    Clin Rheumatol. 2025;44:1225-1236.
    >> Share

  77. VIEGAS-COSTA LC, Friesen R, Lai H, McGaw T, et al
    Serology and histology in Sjogren's syndrome diagnosis: a retrospective accuracy study.
    Clin Rheumatol. 2025;44:1197-1207.
    >> Share

    February 2025
  78. LI Y, Zhong S, Huang S, Zhong W, et al
    Application of metabolomics in the classification of traditional Chinese medicine syndromes in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 26. doi: 10.1007/s10067-025-07373.
    >> Share

  79. TASAMMA AT, Eshetu BZ, Seyoum AT, Woldegiorgis SA, et al
    Differences in rates of remission between rheumatoid factor positive and negative rheumatoid arthritis patients: experience from a resource-limited setting.
    Clin Rheumatol. 2025 Feb 25. doi: 10.1007/s10067-025-07370.
    >> Share

  80. VISWANATHAN A, Brahma N, Vimal S
    The future of autoimmune disease care: merging genomic insights and imaging for enhanced prognosis in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 22. doi: 10.1007/s10067-024-07234.
    >> Share

  81. SAIDI AN, Theel WB, Burggraaf B, van der Lelij AJ, et al
    Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 17. doi: 10.1007/s10067-025-07364.
    >> Share

  82. WU H, Yin F, Wang Y, Tang Z, et al
    Increased macrophage migration inhibitory factor is associated with inflammation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 14. doi: 10.1007/s10067-025-07361.
    >> Share

  83. MIKAEILI B, Alqahtani ZA, Hincapie AL, Guo JJ, et al
    Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022.
    Clin Rheumatol. 2025 Feb 13. doi: 10.1007/s10067-025-07360.
    >> Share

  84. MUSAEVA LM, Shestakova KM, Baskhanova SN, Varzieva VG, et al
    Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions.
    Clin Rheumatol. 2025 Feb 10. doi: 10.1007/s10067-025-07355.
    >> Share

  85. NANKI T, Yamaguchi T, Umetsu K, Tanabe R, et al
    Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07328.
    >> Share

  86. WANG H, Chu J, Wang Y, Wu Y, et al
    Mediating effect of X-26109 on the causal relationship between CD14(+) CD16(-) monocyte activation complex and rheumatoid arthritis in Europe.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07300.
    >> Share

  87. HAMMAM N, El-Hadidi T, El-Hadidi K, Elsaman A, et al
    International overview on juvenile-, adult- and elderly-onset rheumatoid arthritis: The age at disease onset as a fundamental determinant of clinical presentation.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07356.
    >> Share

  88. QWABE N, Paruk F, Mody GM
    Low prevalence of methotrexate intolerance in rheumatoid arthritis: a South African study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07310.
    >> Share

  89. XIE X, Wei G, Tang Z, Chen H, et al
    Investigating the causal relationship between rheumatoid arthritis and cardiovascular disease: A Mendelian randomization study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07357.
    >> Share

  90. WU B, Dong Q, Zhang Q, Jin F, et al
    Protective effects of Catalpol to attenuate TNF- alpha and collagen-induced inflammation in vitro HFLS-RA cells and in vivo mice models for the treatment of rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 5. doi: 10.1007/s10067-024-07261.
    >> Share

  91. LONG D, Zhan J, Tu C, Yu S, et al
    Analysis of expression and its clinical significance of the ADAMTS-2 in systemic lupus erythematosus.
    Clin Rheumatol. 2025;44:681-691.
    >> Share

  92. LIAO Q, Zhao Y, Li X, Li X, et al
    Cerebral venous thrombosis as a rare complication of Sjogren's syndrome: case series and literature review.
    Clin Rheumatol. 2025;44:739-746.
    >> Share

    January 2025
  93. MOHAN A, Mohan A, Ramachandran A, Pulinilkunnathil JG, et al
    Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predispositio
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07351.
    >> Share

  94. UZUN GS, Sarikaya Y, Arslan S, Ekici M, et al
    ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07344.
    >> Share

  95. PERNIOLA S, Bruno D, Di Mario C, Campobasso D, et al
    Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission.
    Clin Rheumatol. 2025 Jan 22. doi: 10.1007/s10067-025-07331.
    >> Share

  96. HUANG Y, Li T, An Y, Lu D, et al
    Molecular mechanism of osteoclast differentiation of PBMC in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jan 18. doi: 10.1007/s10067-025-07322.
    >> Share

  97. XU B, Yu C
    Letter to editor "Health?related quality of life (HRQoL) loss associated with self?perceived anxiety/depression in seropositive rheumatoid arthritis".
    Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-024-07260.
    >> Share

  98. SENER S, Sener YZ
    Letter to the editor: Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findi
    Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-025-07330.
    >> Share

  99. WU S, Xie Y, Jiang Y, Zhang X, et al
    GTS-21 modulates rheumatoid arthritis Th17 and Th2 lymphocyte subset differentiation through the a7nAch receptor.
    Clin Rheumatol. 2025 Jan 15. doi: 10.1007/s10067-025-07320.
    >> Share

  100. HU X, Liu X, Xu Y, Zhang S, et al
    Machine learning-based prediction model integrating ultrasound scores and clinical features for the progression to rheumatoid arthritis in patients with undifferentiated arthritis.
    Clin Rheumatol. 2025 Jan 10. doi: 10.1007/s10067-025-07304.
    >> Share

  101. ALRIFAI N, Puttur A, Ghanem F, Dhital Y, et al
    Maternal and fetal outcomes in those with autoimmune connective tissue disease.
    Clin Rheumatol. 2025;44:391-401.
    >> Share

  102. KOPPEJAN H, Smith SI, Hameetman M, Toes REM, et al
    A small-scale preliminary study utilizing mass cytometry to distinguish two forms of arthritis.
    Clin Rheumatol. 2025;44:495-502.
    >> Share

  103. MANDOSI C, Matys V, Deroma M, Del Negro V, et al
    Ovarian reserve in patients with Sjogren's syndrome: a cross-sectional study.
    Clin Rheumatol. 2025;44:319-325.
    >> Share

  104. FAYET F, Beauvais C, Pereira B, Beranger M, et al
    Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial.
    Clin Rheumatol. 2025;44:487-494.
    >> Share

  105. PANG R, Ma X, Guo H, Qi X, et al
    Meta-analysis of mortality-associated factors in primary Sjogren's syndrome patients with interstitial lung disease.
    Clin Rheumatol. 2025;44:23-31.
    >> Share

    December 2024
  106. TANG M, Du L, Peng J
    Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018.
    Clin Rheumatol. 2024 Dec 30. doi: 10.1007/s10067-024-07272.
    >> Share

  107. ZHOU W, Yang Y, Su L
    Development and validation of predictive factors influencing rheumatoid arthritis associated with interstitial lung disease.
    Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07282.
    >> Share

  108. HIJJAWI N, Tout FS, Azaizeh B, Aljaafreh B, et al
    The role of vitamins D, B12, C, and K in modulating inflammation and disease management in rheumatoid arthritis: a comprehensive review.
    Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07285.
    >> Share

  109. WAN J, Cao X, Yang Y
    Decreased in-hospital mortality in shock patients with rheumatoid arthritis compared to those without: a retrospective analysis of a critical care database.
    Clin Rheumatol. 2024 Dec 24. doi: 10.1007/s10067-024-07280.
    >> Share

  110. HARROLD LR, Bingham CO, Pope JE, O'Brien J, et al
    Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.
    Clin Rheumatol. 2024 Dec 20. doi: 10.1007/s10067-024-07245.
    >> Share

  111. ZHAN W, Li R, Xu X
    The relationship between low-carbohydrate diet score, dietary macronutrient intake, and rheumatoid arthritis: results from NHANES 2011-2016.
    Clin Rheumatol. 2024 Dec 16. doi: 10.1007/s10067-024-07269.
    >> Share

  112. GUAJARDO-JAUREGUI N, Cardenas-de la Garza JA, Galarza-Delgado DA, Azpiri-Lopez JR, et al
    Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican coh
    Clin Rheumatol. 2024 Dec 10. doi: 10.1007/s10067-024-07249.
    >> Share

  113. YANG L, Wang X, Gu B, Su D, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of pulmonary arterial hypertension.
    Clin Rheumatol. 2024 Dec 6. doi: 10.1007/s10067-024-07258.
    >> Share

  114. FENG R, Xiao X, Wang Y, Huang B, et al
    Metabolic impact of low dose IL-2 therapy for primary Sjogren's Syndrome in a double-blind, randomized clinical trial.
    Clin Rheumatol. 2024;43:3789-3798.
    >> Share

  115. SHUAI XU, Dandan F, Liang XU
    Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica.
    Clin Rheumatol. 2024;43:3993-3998.
    >> Share

  116. TEIXEIRA RL, da Silva Vieira R, Saavedra MJ, Polido-Pereira J, et al
    Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study.
    Clin Rheumatol. 2024;43:3941-3950.
    >> Share

  117. WANG X, Wu H, Zhong B, Zhang L, et al
    Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:3781-3787.
    >> Share

  118. PENG LQ, Chen XH, Yang WJ, Huang WK, et al
    Can unstimulated whole salivary flow objectively classify salivary gland secretory function in Sjogren's syndrome?
    Clin Rheumatol. 2024;43:3771-3780.
    >> Share

    November 2024
  119. PANG X, Xu F, Fan C, Jiang H, et al
    Global research trends of MicroRNAs in rheumatoid arthritis: bibliometrics and visualization analysis.
    Clin Rheumatol. 2024 Nov 28. doi: 10.1007/s10067-024-07250.
    >> Share

  120. JIANG P, Shen Y, Chang C, Shi Y, et al
    HIPK3 hypomethylation as a potential epigenetic biomarker in rheumatic immune diseases with emphasis on rheumatoid arthritis.
    Clin Rheumatol. 2024 Nov 27. doi: 10.1007/s10067-024-07158.
    >> Share

  121. YAN L, Lin M, Ye X, Li W, et al
    Prediction model for bone erosion in rheumatoid arthritis based on musculoskeletal ultrasound and clinical risk factors.
    Clin Rheumatol. 2024 Nov 9. doi: 10.1007/s10067-024-07219.
    >> Share

  122. LYU Q, Ma L, Liu H, Shao H, et al
    Weight-adjusted waist index associated with bone mineral density in rheumatoid arthritis patients: a cross-sectional study.
    Clin Rheumatol. 2024 Nov 5. doi: 10.1007/s10067-024-07179.
    >> Share

  123. DAGHOR-ABBACI K, Laraba N, Dahou-Makhloufi C, Mechid F, et al
    Disease activity score for still's disease.
    Clin Rheumatol. 2024;43:3273-3283.
    >> Share

  124. CAI X, Jin J, Ye H, Xiang X, et al
    Altered serum metabolome is associated with disease activity and immune responses in rheumatoid arthritis.
    Clin Rheumatol. 2024 Nov 1. doi: 10.1007/s10067-024-07201.
    >> Share

    October 2024
  125. MAHMOUD EM, Radwan A, Elsayed SA
    A prospective randomized-controlled non-blinded comparative study of the JAK inhibitor (baricitinib) with TNF-alpha inhibitors and conventional DMARDs in a sample of Egyptian rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Oct 31. doi: 10.1007/s10067-024-07194.
    >> Share

  126. ROJAS-GUALDRON DF, Franco-Salazar C, Gomez-Henck CA, Manrique-Castrillon MC, et al
    Health-related quality of life (HRQoL) loss associated with self-perceived anxiety/depression in seropositive rheumatoid arthritis.
    Clin Rheumatol. 2024 Oct 30. doi: 10.1007/s10067-024-07186.
    >> Share

  127. D'ONOFRIO B, Selmi C, Gremese E
    Are seronegative patients with rheumatoid arthritis and clinically suspect arthralgia properly represented in randomized clinical trials?
    Clin Rheumatol. 2024 Oct 26. doi: 10.1007/s10067-024-07187.
    >> Share

  128. LI S, Chen Z, Yu H, Chang W, et al
    Association of magnesium deficiency scores with risk of rheumatoid arthritis and osteoarthritis in adults: a cross-sectional population-based study.
    Clin Rheumatol. 2024 Oct 25. doi: 10.1007/s10067-024-07203.
    >> Share

  129. TAHIR MW, Rosli Y, Leung C, Wysham KD, et al
    Frailty and its association with readmissions in patients with rheumatoid arthritis: A national readmissions database study.
    Clin Rheumatol. 2024 Oct 19. doi: 10.1007/s10067-024-07200.
    >> Share

  130. SHIH PC, Hung PC, Leong PY, Hsu JN, et al
    Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study.
    Clin Rheumatol. 2024 Oct 11. doi: 10.1007/s10067-024-07161.
    >> Share

  131. ZHAO CN, Jiang LQ, Musonye HA, Meng SY, et al
    Associations of accelerated biological aging and metabolic heterogeneity of obesity with rheumatoid arthritis: a prospective cohort study.
    Clin Rheumatol. 2024 Oct 5. doi: 10.1007/s10067-024-07167.
    >> Share

  132. MOVAHEDI M, Cui K, Tomlinson G, Cesta A, et al
    Functional disability and disease activity are affected by social determinants of health in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Oct 4. doi: 10.1007/s10067-024-07148.
    >> Share

  133. LIN Q, Zhang C, Huang H, Bai Z, et al
    TLR2 reprograms glucose metabolism in CD4(+) T cells of rheumatoid arthritis patients to mediate cell hyperactivation and TNF-alpha secretion.
    Clin Rheumatol. 2024 Oct 2. doi: 10.1007/s10067-024-07125.
    >> Share

  134. XIA Z, Zong S, Zhou S, Rao Y, et al
    Rheumatoid arthritis and gliostatin: a two-sample Mendelian randomization analysis and RT-PCR validation.
    Clin Rheumatol. 2024 Oct 1. doi: 10.1007/s10067-024-07164.
    >> Share

  135. PHAN K, Chou S, Lee AYS
    Isolated cutaneous panniculitis in Sjogren's disease exacerbated by COVID-19 illness.
    Clin Rheumatol. 2024;43:3257-3258.
    >> Share

    September 2024
  136. SHI X
    Letter to the editor: "Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study".
    Clin Rheumatol. 2024 Sep 30. doi: 10.1007/s10067-024-07150.
    >> Share

  137. ANJIKI K, Hayashi S, Ikuta K, Suda Y, et al
    JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.
    Clin Rheumatol. 2024 Sep 20. doi: 10.1007/s10067-024-07142.
    >> Share

  138. ZHANG L, Shen Y
    Letter to the editor to "Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study".
    Clin Rheumatol. 2024 Sep 19. doi: 10.1007/s10067-024-07112.
    >> Share

  139. OU Y, Wu J, Zhu Y, Qi X, et al
    Application of superb microvascular imaging technology in clinical disease activity of rheumatoid arthritis.
    Clin Rheumatol. 2024 Sep 12. doi: 10.1007/s10067-024-07119.
    >> Share

  140. HAYASHI S, Nakano N, Tsubosaka M, Kamenaga T, et al
    Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.
    Clin Rheumatol. 2024 Sep 7. doi: 10.1007/s10067-024-07117.
    >> Share

  141. SUAREZ-ALMAZOR ME, Ruiz JI, Lei X, Wu CF, et al
    Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer.
    Clin Rheumatol. 2024 Sep 4. doi: 10.1007/s10067-024-07135.
    >> Share

  142. ZAYENI H, Sojoudi S, Ghanbari AM, Masooleh IS, et al
    The effect of radiation synovectomy with phosphorus-32 on the pain and swelling in 31 RA patients with resistant monoarthritis of the knee.
    Clin Rheumatol. 2024;43:2791-2798.
    >> Share

    August 2024
  143. WANG X, Bai Y, Zou X, He X, et al
    Exploring the role of Life Essential 8 in patients diagnosed with systemic lupus erythematosus and rheumatoid arthritis.
    Clin Rheumatol. 2024 Aug 21. doi: 10.1007/s10067-024-07114.
    >> Share

  144. MALANI K, Pradhan S, Roberts M, Saquib N, et al
    Joint effect of rheumatoid arthritis and diet quality on cardiovascular and mortality outcomes: insights from the Women's Health Initiative.
    Clin Rheumatol. 2024 Aug 4. doi: 10.1007/s10067-024-07092.
    >> Share

  145. WANG X, Yang J, Yu LY, Zhang J, et al
    Effect of disease duration on the use of tofacitinib: a real-world study in elderly patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07084.
    >> Share

  146. CHEN DY
    Reply to "Letter to the Editor": Exploring Multidimensional Factors of Herpes Zoster Risk in Rheumatoid Arthritis Patients Undergoing JAK Inhibitor Treatment.
    Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07087.
    >> Share

  147. JERIES H, Daood R, Naffaa ME
    Is interleukin-1 blockade a therapeutic option for patients with palindromic rheumatism?
    Clin Rheumatol. 2024;43:2715-2717.
    >> Share

  148. ZHU H, Wang Y, Wang G, Ling Y, et al
    The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjogren's syndrome.
    Clin Rheumatol. 2024;43:2585-2594.
    >> Share

    July 2024
  149. PARK E, Iqbal R, Giles JT, Bernstein EJ, et al
    Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis-associated interstitial lung disease: a survey of rheumatologists.
    Clin Rheumatol. 2024 Jul 31. doi: 10.1007/s10067-024-07068.
    >> Share

  150. GU H, Yan D, Li J, Long X, et al
    Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.
    Clin Rheumatol. 2024 Jul 29. doi: 10.1007/s10067-024-07083.
    >> Share

  151. TONG B, Cheng W
    Letter to editor 'Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease'.
    Clin Rheumatol. 2024 Jul 22. doi: 10.1007/s10067-024-07075.
    >> Share

  152. ZHOU L, Xing Y, Li W
    Exploring multidimensional factors of herpes zoster risk in rheumatoid arthritis patients undergoing JAK inhibitor treatment.
    Clin Rheumatol. 2024 Jul 20. doi: 10.1007/s10067-024-07076.
    >> Share

  153. NOVELLA-NAVARRO M, Ruiz-Esquide V, Lopez-Juanes N, Chacur CA, et al
    Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
    Clin Rheumatol. 2024 Jul 16. doi: 10.1007/s10067-024-07070.
    >> Share

  154. CHEN PK, Chang SH, Chen YM, Chen HH, et al
    Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study.
    Clin Rheumatol. 2024 Jul 2. doi: 10.1007/s10067-024-07041.
    >> Share

  155. FAYET F, Darmant N, Lambert C, Pereira B, et al
    Effect of Argentine tango sessions on total physical activity time in patients with chronic inflammatory rheumatism: randomized, controlled, pilot study.
    Clin Rheumatol. 2024;43:2215-2221.
    >> Share

  156. SOLTANI F, Khalaji A, Farzaneh R, Malek Mahdavi A, et al
    Performance of existing diagnostic criteria for palindromic rheumatism.
    Clin Rheumatol. 2024;43:2337-2342.
    >> Share

  157. ANSARI N, Salesi M
    The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies.
    Clin Rheumatol. 2024;43:2177-2186.
    >> Share

    June 2024
  158. WANG W, Xu Y, Zhou J, Zang Y, et al
    Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07040.
    >> Share

  159. JANAHIRAMAN S, Shahril NS, Jayaraj VJ, Ch'ng S, et al
    A hierarchical cluster analysis for clinical profiling of tofacitinib treatment response in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07035.
    >> Share

  160. LIU F, Liu F, Wang H
    Association between Life's Essential 8 and rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 24. doi: 10.1007/s10067-024-07036.
    >> Share

  161. VENKAT RK, Hayashi K, Juge PA, McDermott G, et al
    Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2024 Jun 19. doi: 10.1007/s10067-024-07028.
    >> Share

  162. GADEHOLT O, Arnold E, Gorman C, Mueller T, et al
    Body mass index stratification enables cytokine-based prediction of ACPA status and Power-Doppler disease activity in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 14. doi: 10.1007/s10067-024-07032.
    >> Share

  163. HARRIS JT, Yang Y, Bentley JP, Chen Y, et al
    Estimation of optimal adherence threshold for tumor necrosis factor inhibitors in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 10. doi: 10.1007/s10067-024-06971.
    >> Share

  164. OPDAM MAA, Broeder ND, van den Bemt BJF, Mulder K, et al
    Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
    Clin Rheumatol. 2024;43:2133-2138.
    >> Share

  165. SARIYILDIZ A, Coskun Benlidayi I, Yetisir A, Turk I, et al
    Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1949-1958.
    >> Share

  166. GOLOVINA OA, Torgashina AV, Gorodetskiy VR, Sockol EV, et al
    Combination of Sjogren's syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature.
    Clin Rheumatol. 2024;43:2145-2152.
    >> Share

  167. LIU H, Yuan J, Tan X, Song W, et al
    Male patients with primary Sjogren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.
    Clin Rheumatol. 2024;43:1927-1937.
    >> Share

  168. XIE Y, Fan Y, Su M, Wang Y, et al
    Characteristics of the oral microbiota in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1939-1947.
    >> Share

  169. EL MIEDANY Y, El Gaafary M, Youssef S, El Aroussy N, et al
    Meaningful patient engagement in inflammatory arthritis: development of the Patient Motivation Questionnaire.
    Clin Rheumatol. 2024;43:1793-1801.
    >> Share

    May 2024
  170. CHEN G, Chen H, Wang Z, Cai H, et al
    Letter to the editor: "Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis".
    Clin Rheumatol. 2024 May 18. doi: 10.1007/s10067-024-07006.
    >> Share

  171. ABDULSALAM AJ, Analay P, Kara M
    Sarcopenia in rheumatoid arthritis: choose your weapons wisely.
    Clin Rheumatol. 2024 May 13. doi: 10.1007/s10067-024-07002.
    >> Share

  172. MURPHY L, Saab MM, Cornally N, McHugh S, et al
    Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review.
    Clin Rheumatol. 2024 May 11. doi: 10.1007/s10067-024-06996.
    >> Share

  173. WAN J, Yu Z, Cao X, Zhao X, et al
    Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2024 May 5. doi: 10.1007/s10067-024-06984.
    >> Share

  174. HU W, Ding Y, Guan K, Zhang P, et al
    Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy.
    Clin Rheumatol. 2024 May 2. doi: 10.1007/s10067-024-06982.
    >> Share

  175. XU N, Wang X, Dai T, Liu N, et al
    Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjogren syndrome.
    Clin Rheumatol. 2024;43:1683-1692.
    >> Share

  176. LU L, Dai T, Zhao Y, Qu H, et al
    The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1675-1682.
    >> Share

  177. CAI B, Guo Z, Yan Q, Li H, et al
    Clinical features and risk factors of primary Sjogren's syndrome complicated with severe pneumonia: a case-control study.
    Clin Rheumatol. 2024;43:1665-1674.
    >> Share

  178. AN Q, Ma R, Yuan D, Huang J, et al
    Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.
    Clin Rheumatol. 2024;43:1491-1501.
    >> Share

  179. LI H, Jin Y, He J
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:1777.
    >> Share

    April 2024
  180. SEPRIANO A, Ramiro S, Landewe R, van der Heijde D, et al
    Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
    Clin Rheumatol. 2024 Apr 29. doi: 10.1007/s10067-024-06978.
    >> Share

  181. LOZADA-MELLADO M, Llorente L, Hinojosa-Azaola A, Ogata-Medel M, et al
    Inflammatory profile in patients with rheumatoid arthritis and sarcopenia.
    Clin Rheumatol. 2024 Apr 26. doi: 10.1007/s10067-024-06974.
    >> Share

  182. SHEAHAN A, Anjohrin S, Suruki R, Stark JL, et al
    Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
    Clin Rheumatol. 2024 Apr 25. doi: 10.1007/s10067-024-06945.
    >> Share

  183. LITTLEJOHN G, Anbumurali N, O'Sullivan C, Smith T, et al
    Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
    Clin Rheumatol. 2024 Apr 18. doi: 10.1007/s10067-024-06967.
    >> Share

  184. YETISIR A, Sariyildiz A, Turk I, Coskun Benlidayi I, et al
    Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors.
    Clin Rheumatol. 2024 Apr 15. doi: 10.1007/s10067-024-06963.
    >> Share

  185. ZHOU J, Gan Y, Fan X, Qi H, et al
    Latent class analysis of psychological resilience and influencing factors in patients with rheumatoid arthritis: a cross-sectional survey.
    Clin Rheumatol. 2024 Apr 10. doi: 10.1007/s10067-024-06959.
    >> Share

  186. YU T, Qian S, Li M
    Letter to the Editor: "Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis".
    Clin Rheumatol. 2024 Apr 6. doi: 10.1007/s10067-024-06924.
    >> Share

  187. OLIVEIRA D, Ferreira RM, Gomes CM, Vaz C, et al
    Geiser Sign in a patient with rheumatoid arthritis.
    Clin Rheumatol. 2024 Apr 4. doi: 10.1007/s10067-024-06952.
    >> Share

  188. XIE Y, Zhao H
    Real respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1353.
    >> Share

  189. DAI W, He H
    Commentary on the respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1419-1420.
    >> Share

  190. LIU X, Wang H, Wang X, Jiang X, et al
    Identification and verification of inflammatory biomarkers for primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1335-1352.
    >> Share

    March 2024
  191. BIRD A, Oakden-Rayner L, Smith LA, Zeng M, et al
    Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.
    Clin Rheumatol. 2024 Mar 27. doi: 10.1007/s10067-024-06946.
    >> Share

  192. GUPTA N, Kanwar N, Arora A, Khatri K, et al
    The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
    Clin Rheumatol. 2024 Mar 18. doi: 10.1007/s10067-024-06932.
    >> Share

  193. LU F, Chen Q, Qi X, Cong M, et al
    Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters.
    Clin Rheumatol. 2024 Mar 16. doi: 10.1007/s10067-024-06931.
    >> Share

  194. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Mar 15. doi: 10.1007/s10067-024-06907.
    >> Share

  195. ATHANASSIOU P, Katsimbri P, Bounas A, Gazi S, et al
    Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational
    Clin Rheumatol. 2024 Mar 12. doi: 10.1007/s10067-024-06916.
    >> Share

  196. OZ N, Gezer HH, Cilli Hayiroglu S, Duruoz MT, et al
    Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Mar 11. doi: 10.1007/s10067-024-06927.
    >> Share

  197. PAN J, Wu T, Ma JD, Jia PW, et al
    Geriatric nutrition risk index: a more powerful index identifying muscle mass loss in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Mar 4. doi: 10.1007/s10067-024-06918.
    >> Share

  198. SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
    Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Clin Rheumatol. 2024;43:1245-1251.
    >> Share

  199. BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
    Sjogren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
    Clin Rheumatol. 2024;43:1093-1101.
    >> Share

  200. BAO X
    Validation of new immune and inflammation-related diagnostic biomarkers for RA.
    Clin Rheumatol. 2024;43:949-958.
    >> Share

  201. ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
    Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study.
    Clin Rheumatol. 2024;43:1253-1259.
    >> Share

  202. PHAM C, Niu F, Hui RL, Le KN, et al
    Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto.
    Clin Rheumatol. 2024;43:1269-1270.
    >> Share

    February 2024
  203. CHEN D, Zhang J
    Commentary on the factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
    >> Share

  204. WANG B, Liu J, Zhao L
    Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study.
    Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
    >> Share

  205. FERNANDEZ-AVILA DG, Patino-Hernandez D, Moreno-Luna S, Brance L, et al
    Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 14. doi: 10.1007/s10067-024-06868.
    >> Share

  206. LICHTIGER A, Fadaei G, Tagoe CE
    Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet.
    Clin Rheumatol. 2024 Feb 10. doi: 10.1007/s10067-024-06888.
    >> Share

  207. NOMAIR AM, Abdelati A, Dwedar FI, Elnemr R, et al
    The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Feb 5. doi: 10.1007/s10067-024-06892.
    >> Share

  208. ZHANG L, Tan M, Mao J, Zhang J, et al
    Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 2. doi: 10.1007/s10067-024-06871.
    >> Share

  209. LERCARA A, Malattia C, Hysa E, Gattorno M, et al
    Microvascular status in juvenile Sjogren's disease: the first nailfold videocapillaroscopy investigation.
    Clin Rheumatol. 2024;43:733-741.
    >> Share

  210. ZHAO R, Dong C, Gu Z, Ding X, et al
    Development and validation of a nomogram for predicting fatigue in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:717-724.
    >> Share

  211. ZHOU X, Li H, Wang N, Jin Y, et al
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:707-715.
    >> Share

  212. SHEN Y, Yu X, Wang Q, Yao X, et al
    Association between primary Sjogren's syndrome and gut microbiota disruption: a systematic review and meta-analysis.
    Clin Rheumatol. 2024;43:603-619.
    >> Share

    January 2024
  213. O'BRIEN J, Park SH, Blachley T, Marchese M, et al
    Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups.
    Clin Rheumatol. 2024 Jan 25. doi: 10.1007/s10067-024-06869.
    >> Share

  214. QIAO L, Lv S, Meng K, Yang J, et al
    Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
    Clin Rheumatol. 2024 Jan 10. doi: 10.1007/s10067-023-06837.
    >> Share

  215. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Jan 6. doi: 10.1007/s10067-023-06862.
    >> Share

  216. SHIZUKU T, Hagino N
    Hypoglossal nerve palsy due to basilar impression in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jan 3. doi: 10.1007/s10067-023-06863.
    >> Share

  217. YIN S, Luo F, Xie J, Zeng Y, et al
    Identification of discriminatory factors and construction of nomograms for differentiating AOSD and sepsis.
    Clin Rheumatol. 2024;43:569-578.
    >> Share

  218. RUAN Y, Bi H, Luo X, Pang A, et al
    Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjogren syndrome with thrombocytopenia.
    Clin Rheumatol. 2024;43:307-314.
    >> Share

  219. SAMI F, Sami SA, Manadan AM, Arora S, et al
    Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
    Clin Rheumatol. 2024;43:59-65.
    >> Share

  220. FARES J, Summer R, Loizidis G
    Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
    Clin Rheumatol. 2024;43:325-338.
    >> Share

  221. CHEN L, Chi H, Teng J, Meng J, et al
    Neutralizing anti-IFN-gamma IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
    Clin Rheumatol. 2024;43:189-198.
    >> Share

  222. ZHAO P, Peng C, Chang X, Cheng W, et al
    Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:297-306.
    >> Share

  223. KIADALIRI A, Dell'Isola A, Englund M
    Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.
    Clin Rheumatol. 2024;43:81-85.
    >> Share

  224. CAI D, Zheng Z, Hu J, Fu Y, et al
    Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study.
    Clin Rheumatol. 2024;43:533-541.
    >> Share

    December 2023
  225. SLOUMA M, Lahmar W, Mohamed G, Dhrif O, et al
    Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2023 Dec 30. doi: 10.1007/s10067-023-06847.
    >> Share

  226. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
    Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis-results from the Finnish quality register.
    Clin Rheumatol. 2023 Dec 28. doi: 10.1007/s10067-023-06850.
    >> Share

  227. OZUDOGRU CELIK T
    Letter to the Editor on "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06823.
    >> Share

  228. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    Rebuttal Letter to "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06856.
    >> Share

  229. D'ALESSANDRO F, Cazzato M, Laurino E, Morganti R, et al
    ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study
    Clin Rheumatol. 2023 Dec 23. doi: 10.1007/s10067-023-06836.
    >> Share

  230. LIU H, Zhang Y, Cao J, Li J, et al
    Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity.
    Clin Rheumatol. 2023 Dec 14. doi: 10.1007/s10067-023-06840.
    >> Share

  231. MO H, Su ZH, Zheng ZY, Gao L, et al
    Screening for early rheumatoid arthritis using high-frequency ultrasound, serum RANKL, and OPG detection.
    Clin Rheumatol. 2023 Dec 5. doi: 10.1007/s10067-023-06830.
    >> Share

  232. KARAMALI N, Mahmoudi Z, Roghani SA, Assar S, et al
    Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.
    Clin Rheumatol. 2023 Dec 4. doi: 10.1007/s10067-023-06808.
    >> Share

  233. HE J, Xu C, Zhu Y, Xu M, et al
    Clinical significance of the expression levels of serum transforming growth factor-beta and CXC type chemokine ligand 13 in primary Sjogren's syndrome patients.
    Clin Rheumatol. 2023;42:3283-3288.
    >> Share

  234. SCHMIDT NS, Fana V, Danielsen MA, Lindegaard HM, et al
    The impact of an ultrasound atlas for scoring salivary glands in primary Sjogren's syndrome: a pilot study.
    Clin Rheumatol. 2023;42:3275-3281.
    >> Share

  235. YIN H, Yang S, Lu L
    Adie's tonic pupil in primary Sjogren syndrome.
    Clin Rheumatol. 2023;42:3419-3420.
    >> Share

    November 2023
  236. SHAMSI A, Roghani SA, Soufivand P, Pournazari M, et al
    CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 25. doi: 10.1007/s10067-023-06826.
    >> Share

  237. PALMOWSKI A, Strehl C, Pfeiffenberger M, Haupl T, et al
    Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 17. doi: 10.1007/s10067-023-06814.
    >> Share

  238. RONG JC, Chen XD, Jin NK, Hong J, et al
    Exploring the causal association of rheumatoid arthritis with atrial fibrillation: a Mendelian randomization study.
    Clin Rheumatol. 2023 Nov 6. doi: 10.1007/s10067-023-06804.
    >> Share

  239. HUANG Y, Qiu Y, Xie Z, Zhang F, et al
    Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case?control study.
    Clin Rheumatol. 2023;42:3033-3041.
    >> Share

  240. MASHAYEKHI M, Khalaji A, Malek Mahdavi A, Khabbazi A, et al
    Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study.
    Clin Rheumatol. 2023;42:3143-3152.
    >> Share

  241. SANTOS CS, Salgueiro RR, Morales CM, Castro CA, et al
    Risk factors for cardiovascular disease in primary Sjogren's syndrome (pSS): a 20-year follow-up study.
    Clin Rheumatol. 2023;42:3021-3031.
    >> Share

  242. WISE L, Zell M
    Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
    Clin Rheumatol. 2023;42:3159-3166.
    >> Share

    October 2023
  243. ADELOWO O, Omokhowa A, Ochiagha O, Uhunmwangho CU, et al
    Comorbidities in Nigerian patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 23. doi: 10.1007/s10067-023-06797.
    >> Share

  244. VALLEZ-VALERO L, Gaso-Gago I, Marcos-Fendian A, Garrido-Alejos G, et al
    Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06787.
    >> Share

  245. LI WJ, Wang XL, Chu YR, Wang JX, et al
    Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06784.
    >> Share

  246. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients.
    Clin Rheumatol. 2023 Oct 9. doi: 10.1007/s10067-023-06780.
    >> Share

  247. PAN S, Xiao X, Li T, Wu S, et al
    Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 4. doi: 10.1007/s10067-023-06772.
    >> Share

  248. TESCH F, Ehm F, Vivirito A, Wende D, et al
    Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
    Clin Rheumatol. 2023;42:2905-2914.
    >> Share

  249. ZIMBA O, Gasparyan AY
    Cardiovascular issues in rheumatic diseases.
    Clin Rheumatol. 2023;42:2535-2539.
    >> Share

  250. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
    Clin Rheumatol. 2023;42:2677-2690.
    >> Share

    September 2023
  251. WEINSTEIN CLJ, Meehan AG, Lin J, Briscoe SD, et al
    Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Clin Rheumatol. 2023 Sep 26. doi: 10.1007/s10067-023-06760.
    >> Share

  252. LIU H, Li Q, Long K, Xia O, et al
    Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.
    Clin Rheumatol. 2023 Sep 23. doi: 10.1007/s10067-023-06773.
    >> Share

  253. NAKAYAMA M, Furuya T, Inoue E, Tanaka E, et al
    Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
    Clin Rheumatol. 2023 Sep 21. doi: 10.1007/s10067-023-06779.
    >> Share

  254. RAZMJOU AA, Wang JM, Shahbazian A, Reddy S, et al
    Correction to: Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 14. doi: 10.1007/s10067-023-06768.
    >> Share

  255. CHEN YW, Chen HH, Huang WN, Chen JP, et al
    Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 2. doi: 10.1007/s10067-023-06735.
    >> Share

    November 2022
  256. CANSU DU, Korkmaz C
    Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Clin Rheumatol. 2022 Nov 17. pii: 10.1007/s10067-022-06446.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016